LAVA Therapeutics NV Quarterly Retained Earnings (Accumulated Deficit) in USD from Q4 2023 to Q4 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The cumulative amount of the reporting entity's undistributed earnings or deficit.
-
Summary
-
LAVA Therapeutics NV quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2023 to Q4 2024.
- LAVA Therapeutics NV Retained Earnings (Accumulated Deficit) for the quarter ending December 31, 2024 was -$175M, a 16.8% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)